Security record · archived quarter
ANRO
Alto Neuroscience, Inc. · Healthcare · Biotechnology
12Tracked holders
0Δ holders
4.77MShares held
$10.50MReported value
+1New positions
−1Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -8.1% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 56 | +2 | 11.55M | $304.50M | +10 | −8 |
| Q1 2026 | 55 | +7 | 8.39M | $188.63M | +8 | −1 |
| Q4 2025 | 48 | +2 | 8.42M | $149.83M | +3 | −1 |
| Q3 2025 | 15 | +1 | 4.77M | $19.16M | +1 | — |
| Q2 2025 | 12 | 0 | 4.77M | $10.50M | +1 | −1 |
| Q1 2025 | 9 | +1 | 3.54M | $7.65M | +2 | −1 |
| Q4 2024 | 8 | +2 | 5.27M | $22.30M | +2 | — |
| Q3 2024 | 5 | 0 | 2.33M | $26.66M | +2 | −2 |
| Q2 2024 | 5 | — | 1.98M | $21.15M | — | — |
Who holds it · Q2 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management ✦ | 1.33M | +7.2% | $2.93M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 2 | The Vanguard Group ✦ (passive) | 1.08M | — | $2.39M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | The Vanguard Group ✦ (passive) | 1.08M | — | $2.39M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Marshall Wace ✦ | 937.41K | +9.9% | $2.06M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Marshall Wace ✦ | 937.41K | +9.9% | $2.06M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | BlackRock ✦ (passive) | 561.85K | — | $1.24M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passive) | 561.85K | — | $1.24M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passive) | 561.85K | — | $1.24M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passive) | 561.85K | — | $1.24M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passive) | 561.85K | — | $1.24M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passive) | 561.85K | — | $1.24M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Millennium Management ✦ | 302.86K | +1772.0% | $666,296 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Geode Capital Management ✦ (passive) | 229.72K | -52.8% | $505,641 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 14 | Geode Capital Management ✦ (passive) | 229.72K | -52.8% | $505,641 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 15 | State Street Global Advisors ✦ (passive) | 104.73K | -69.1% | $230,415 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 76.51K | +217.5% | $168,326 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 76.51K | +217.5% | $168,326 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 76.51K | +217.5% | $168,326 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 76.51K | +217.5% | $168,326 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | T. Rowe Price ✦ | 59.43K | +10.2% | $131,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 21 | Two Sigma Investments ✦ | 44.73K | +71.1% | $98,417 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 22 | Renaissance Technologies ✦ | 34.70K | New | $76,340 | 0.0% | New | 1 | SEC ↗ |
| 23 | Fidelity (FMR) ✦ | 8.30K | — | $18,253 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Renaissance Technologies | $76,340 | 0.0% |
Exited
| Citadel Advisors | $1.08M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 108 holders, 26.83M shares, $592.78M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2025 ·
Methodology ·
Get this via the API